a hrefhttps:www.fiercepharma.commarketinggastroenterologists-spot-treatment-gaps-clinical-remission-rates-durability-among-ibd hreflangenGastroenterologists flag clinical remission and its durability as unmet needs in IBD care: surveya
A survey of 36 U.S. gastroenterologists found that significant treatment gaps remain in the growing IBD drug market despite an expanding range of therapies.
Read the full story at Fierce Pharma ↗